- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07630428
Testing STAR and TextSTAR: A Randomized Controlled Trial
Studie Overzicht
Toestand
Gedetailleerde beschrijving
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Kentucky
-
Louisville, Kentucky, Verenigde Staten, 40202
- University of Louisville Health
-
-
North Carolina
-
Chapel Hill, North Carolina, Verenigde Staten, 27599
- University of North Carolina
-
-
Wisconsin
-
Madison, Wisconsin, Verenigde Staten, 53792
- University of Wisconsin
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- 18 or older
- Can read and respond to questions in English
- Are receiving a SAMFE exam for a assault/victimization within the previous week (7 days)
- Not currently or about to be hospitalized for severe injuries, suicidality, or psychosis
- Not currently or about to be incarcerated
Exclusion Criteria:
- Under age 18
- Those who cannot read and respond to questionnaires in English
- Those seeking care that does not include a SAMFE exam
- Those who cannot consent to receive SAMFE care
- Those who are currently or about to be hospitalized for severe injuries, suicidality, or psychosis
- Those who are currently or about to be incarcerated
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Faculteitstoewijzing
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Video, Bovendrempel, Tekst
Deelnemers aan deze aandoening ontvangen de STAR-interventievideo en degenen die na 1 week de drempel voor PTSS of opioïdenmisbruik overschrijden, worden gerandomiseerd om de textSTAR-interventie te ontvangen.
|
een dagelijks tekstprogramma van drie weken met ondersteunende/bekrachtigende berichten en korte coping-tips om veilige maar beangstigende situaties niet te vermijden, om te gaan met problemen en drang om te gebruiken, en om sociale steun te krijgen om het herstel te bevorderen
a 17-minute video that includes psychoeducation about ptsd and substance misuse plus tips to not avoid safe but scary situations, cope with distress and urges to use, and engage with social support to aid recovery
|
|
Experimenteel: Video, boven drempel, geen tekst
Deelnemers aan deze aandoening ontvangen de STAR-interventievideo en degenen die na 1 week de drempelwaarde voor PTSS of opioïdenmisbruik overschrijden, worden gerandomiseerd om geen textSTAR te ontvangen.
|
a 17-minute video that includes psychoeducation about ptsd and substance misuse plus tips to not avoid safe but scary situations, cope with distress and urges to use, and engage with social support to aid recovery
|
|
Experimenteel: Video, onder de drempel
Deelnemers aan deze aandoening ontvangen de STAR-interventievideo en zijn na 1 week onder de drempelwaarde voor PTSS en opioïdenmisbruik en worden niet gerandomiseerd voor verdere interventie.
|
a 17-minute video that includes psychoeducation about ptsd and substance misuse plus tips to not avoid safe but scary situations, cope with distress and urges to use, and engage with social support to aid recovery
|
|
Experimenteel: Geen video, boven drempel, tekst
Deelnemers aan deze aandoening ontvangen de STAR-interventievideo niet en degenen die na 1 week de drempelwaarde voor PTSS of opioïdenmisbruik overschrijden, worden gerandomiseerd om de textSTAR-interventie te ontvangen.
|
een dagelijks tekstprogramma van drie weken met ondersteunende/bekrachtigende berichten en korte coping-tips om veilige maar beangstigende situaties niet te vermijden, om te gaan met problemen en drang om te gebruiken, en om sociale steun te krijgen om het herstel te bevorderen
|
|
Geen tussenkomst: Geen video, boven de drempel, geen tekst
Deelnemers aan deze aandoening ontvangen de STAR-interventievideo niet en degenen die na 1 week de drempelwaarde voor PTSS of opioïdenmisbruik overschrijden, worden niet gerandomiseerd om de textSTAR-interventie te ontvangen.
|
|
|
Geen tussenkomst: Geen video, onder drempel
Deelnemers aan deze aandoening ontvangen de STAR-interventievideo niet en zijn na 1 week onder de drempelwaarde voor PTSS en opioïdenmisbruik en worden niet gerandomiseerd voor verdere interventie.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Opioid misuse
Tijdsspanne: 1 week
|
Assessed using Tobacco, Alcohol, Prescription Medication, and Other Substance (TAPS) Tool-part 1. The TAPS tool is a brief, two-part assessment of substance use and misuse. The TAPS-1 is a screener with 4 items assessing frequency of use of tobacco, alcohol, prescription medication, and illicit substances on a scale from 0 = never to 4 = daily/almost daily. Any response other than "never" on the TAPS-1 indicates a positive screen, which is used in conjunction with the PCL-5 to determine responder status for randomization to the text program. |
1 week
|
|
Change in acute stress/ posttraumatic stress
Tijdsspanne: 1 week, 1 month, 3 months, 6 months
|
Assessed with PTSD Checklist for DSM-5 (PCL-5).
The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD.
Scores range from 0-80, with scores of 31 or higher indicating probable PTSD.
|
1 week, 1 month, 3 months, 6 months
|
|
Change in Tobacco, Alcohol, and Other Drug Use Frequency
Tijdsspanne: 1 week, 1 month, 3 months, 6 months
|
Assessed using the Timeline Followback (TLFB) Method The Timeline Followback Method (TLFB) is a widely used tool for assessing substance use (alcohol, drugs, cigarettes) that requires individuals to retrospectively report daily use of each type of substance on a calendar.
For alcohol, participants are shown a standard drinks graphic and then asked to report how many drinks they consumed each day on a calendar and how many hours they drank on that day.
For other substances, they are asked to report how many times they used.
|
1 week, 1 month, 3 months, 6 months
|
|
Substance use severity
Tijdsspanne: baseline, 1 month, 3 months, 6 months
|
Assessed with Alcohol, Smoking and Substance Involvement Screening Test (ASSIST; lifetime @ baseline).
The ASSIST is an 8-item questionnaire.
Item 1 maps lifetime use, while Items 2-8 measure frequency, dependence signs, and consequences of use.
Responses for questions 2 through 8 are scored as follows: Never = 0; Once or twice = 1 or 2; Monthly = 2 to 4; Weekly = 3 to 5; and, Daily or almost daily: 4. Scores range from 0-39, where higher scores indicate greater severity of use.
|
baseline, 1 month, 3 months, 6 months
|
|
Depression symptoms
Tijdsspanne: 1 month, 3 months, 6 months
|
Assessed using the Patient Health Questionnaire-9 (PHQ-9) The PHQ-9 is an 9-item questionnaire where participants report how often in the past 2 weeks they were bothered by specific problems.
It is scored on a 4-point Likert scale where 0 = not at all to 3 = nearly every day.
The total possible range of scores is 0-27 where higher scores indicate more depressive symptoms.
|
1 month, 3 months, 6 months
|
|
Mindfulness skills usage
Tijdsspanne: 1 week, 1 month, 3 months, 6 months
|
Assessed with 16 items from the Dialectical Behavior Therapy (DBT) skills subscale of the Ways of Coping Checklist, a 38 item self-report instrument that assesses DBT skills utilization in the past week on a scale from 0 = never used to 3 = used regularly.
The checklist has excellent psychometric properties and has been shown to discriminate patients who received skills training during treatment from those who did not.
Scores range from 0-48, where higher scores reflect greater skills utilization.
|
1 week, 1 month, 3 months, 6 months
|
|
Perceived control over recovery process
Tijdsspanne: 1 month, 3 months, 6 months
|
Assessed with the 8-item Perceived Present Control subscale of the Perceived Control Over Stressful Events Scale.
Statements are rated on a Likert scale ranging from 1 (Very strongly disagree) to 4 (Very strongly agree), with a score range of 8-32, where higher averages indicate stronger perceived control.
The scale has excellent psychometric properties and higher scores (which reflect greater perceived control) have been associated with recovery following sexual violence.
|
1 month, 3 months, 6 months
|
|
Pain severity
Tijdsspanne: baseline, 1 week, 1 month, 3 months, 6 months
|
Assessed with the Brief Pain Inventory (BPI), a 4-item self-report measure that asks participants to rate their worst pain in the last week, their least pain in the last week, their pain on average, and their pain right now on a scale from 0 = no pain at all to 10 = pain as bad as you can imagine.
An overall pain severity score is computed by taking the mean of the four items.
|
baseline, 1 week, 1 month, 3 months, 6 months
|
|
Opioid craving
Tijdsspanne: baseline, 1 week, 1 month, 3 months, 6 months
|
Assessed with the 3-item Opioid Craving Scale which asks participants to rate how strong their desire to use opioids in the past 24-hours was (0 = no desire to use, 9 = extremely strong desire to use), how likely they would be to use if in the same environment when they used to use (0 = not at all likely, 9 = extremely likely), and how strong urges for opioids are when something reminds survivor of opioids (0 = no urge to use, 9 = extreme urge to use).
Items are averaged for a total score (ranging from 0-9).
Only those with any opioid use experience are asked these questions.
|
baseline, 1 week, 1 month, 3 months, 6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Sexual violence stigma
Tijdsspanne: 1 month, 3 months, 6 months
|
Assessed via the 9-item Sexual Violence Related Stigma Scale which asks about individual, interpersonal, and societal aspects of stigma.
It is rated on a 4-point Likert scale, where 0= strongly disagree and 3= strongly agree.
Scores range from 0-27.
Higher total scores indicate a greater severity of sexual violence-related stigma experienced or internalized by the survivor.
|
1 month, 3 months, 6 months
|
|
Emotion dysregulation
Tijdsspanne: 1 month, 3 months, 6 months
|
Assessed via the Difficulties in Emotion Regulation Scale - 16 item version (DERS-16), which asks about the frequency with which individuals experience difficulties in emotion regulation from 1 = not at all to 5 = almost always.
Items are summed so total scores range from 16-80, with higher scores indicating greater difficulties in emotion regulation.
|
1 month, 3 months, 6 months
|
|
Social support
Tijdsspanne: 1 month, 3 months, 6 months
|
Assessed using the The Multidimensional Scale of Perceived Social Support (MSPSS).
MSPSS is a 12-item tool measuring support from family, friends, and significant others using a 7-point Likert scale (1=Very Strongly Disagree to 7=Very Strongly Agree).
Total scores range from 12 to 84, with higher scores indicating greater perceived support.
|
1 month, 3 months, 6 months
|
|
Self-compassion
Tijdsspanne: 1 month, 3 months, 6 months
|
Assessed via 6 items from the Self Compassion Scale-Short Form (SCS-SF) that assess self-kindness, common humanity, and mindfulness on a scale from 1 = almost never to 5 = almost always.
Items are averaged so total scores range from 1-5 where higher scores show higher self compassion.
|
1 month, 3 months, 6 months
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Kate Walsh, PhD, University of Wisconsin, Madison
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Trauma- en stressorgerelateerde aandoeningen
- Narcotica-gerelateerde aandoeningen
- Psychische aandoening
- Middelgerelateerde aandoeningen
- Chemisch veroorzaakte aandoeningen
- Stressstoornissen, Traumatisch
- Aan opioïden gerelateerde aandoeningen
- Stressstoornissen, posttraumatisch
- Technologie, industrie en landbouw
- Technologie
- Bandopname
- Audiovisuele hulpmiddelen
- Educatieve technologie
- Televisie
- Opname van videobanden
Andere studie-ID-nummers
- 2026-0198
- FA (Andere identificatie: UW Madison)
- UWMSN | L&S | Psychology (Andere identificatie: UW Madison)
- 4R33DA059897-03 (Subsidie/contract van de Amerikaanse NIH)
- Protocol Version 6/11/2026 (Andere identificatie: UW Madison)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .